"We still have a lot of work ahead to define what the most informative prediction/scoring VTE systems are, for both newly diagnosed and relapsed/refractory MM patients, and how we can make them more ...

The earliest published study on this topic was a retrospective case–control study by Northup and associates [8] focusing on 113 inpatients with cirrhosis who had newly diagnosed VTE during hospital ...

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...

Approximately 65% of patients with either low or high risk for venous thromboembolism events received excessive prophylaxis, according to findings published in JAMA Internal Medicine. “National ...

Once-daily venous thromboembolism (VTE) prophylaxis with 10 mg of rivaroxaban for either 7 or 28 days after bariatric surgery was found to be effective and safe. Venous thromboembolism (VTE) is known ...

Paul P. Dobesh, PharmD, explained that the approval of betrixaban was important for several reasons: VTE events continue to occur during hospitalization and following discharge, despite the standard ...

Obesity is associated with an increased risk of VTE, and it has been postulated that standard prophylactic LMWH doses may be insufficient to prevent VTE or achieve suggested anti-factor Xa target ...

A clinical-decision tool integrated into electronic health records (EHRs) can help physicians identify patients who are at risk for venous thromboembolism (VTE), implement therapy, and decrease ...

Almost half of outpatient VTE cases can be traced to hospitalization or outpatient surgery; clinicians must, therefore, institute guideline-specified in-hospital prophylaxis, which should be continued ...

Boston, MA (April 30, 2021) - A new set of guidelines, developed by AATS and ESTS (European Society for Thoracic Surgery) presented today at the AATS 101st Annual Meeting, recommends a 30-day course ...

Venous thromboembolism artery. In a study, AKI sufferers had an increased rate of venous thromboembolism whether they receive heparin prophylaxis or not. Current dosing of low-molecular weight (LMWH) ...